Lv11
40 积分 2024-08-16 加入
Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer
2小时前
已完结
Nivolumab plus ipilimumab versus carboplatin-based doublet as first-line treatment for patients with advanced non-small-cell lung cancer aged ≥70 years or with an ECOG performance status of 2 (GFPC 08–2015 ENERGY): a randomised, open-label, phase 3 study
2小时前
已完结
[Chinese expert consensus on lipid management in patients with malignancy]
19天前
已完结
Molecular classification of hepatocellular carcinoma: prognostic importance and clinical applications
28天前
已完结
Oligoreview of Non-Small Cell Lung Cancer Oligometastases
1个月前
已关闭
PD-1/PD-L1抑制剂联合化疗对比贝伐珠单抗联合化疗在非鳞状非小细胞肺癌一线治疗中的疗效及安全性的研究
1个月前
已关闭
[Interpretation and comparison of international guidelines for salivary gland malignancy in 2021]
1个月前
已完结
Rapid Advances in Resectable Non–Small Cell Lung Cancer
2个月前
已完结
Eftilagimod alpha (soluble LAG-3 protein) combined with pembrolizumab as second-line therapy for patients with metastatic head and neck squamous cell carcinoma
2个月前
已完结
皖公网安备34019202002308
